ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.101,00
0,03%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) Notícias

CYTK

Cytokinetics (CYTK)

Cytokinetics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYTK
DataHoraFonteTítuloCódigoCompanhia
17/05/202408:30GlobeNewswire Inc.Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle BiologyNASDAQ:CYTKCytokinetics Inc
16/05/202419:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
15/05/202408:30GlobeNewswire Inc.Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024NASDAQ:CYTKCytokinetics Inc
13/05/202417:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
13/05/202410:33GlobeNewswire Inc.Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 CongressNASDAQ:CYTKCytokinetics Inc
13/05/202410:33GlobeNewswire Inc.Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of MedicineNASDAQ:CYTKCytokinetics Inc
10/05/202417:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTKCytokinetics Inc
08/05/202417:00GlobeNewswire Inc.Cytokinetics Reports First Quarter 2024 Financial ResultsNASDAQ:CYTKCytokinetics Inc
08/05/202408:30GlobeNewswire Inc.Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic CardiomyopathyNASDAQ:CYTKCytokinetics Inc
08/05/202408:30GlobeNewswire Inc.Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586NASDAQ:CYTKCytokinetics Inc
07/05/202417:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
07/05/202417:00GlobeNewswire Inc.Cytokinetics to Hold Annual Meeting of StockholdersNASDAQ:CYTKCytokinetics Inc
02/05/202417:00GlobeNewswire Inc.Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CYTKCytokinetics Inc
29/04/202417:00GlobeNewswire Inc.Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 CongressNASDAQ:CYTKCytokinetics Inc
24/04/202417:00GlobeNewswire Inc.Cytokinetics to Announce First Quarter Results on May 8, 2024NASDAQ:CYTKCytokinetics Inc
10/04/202408:30GlobeNewswire Inc.Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 CongressNASDAQ:CYTKCytokinetics Inc
05/04/202408:30GlobeNewswire Inc.Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific SessionNASDAQ:CYTKCytokinetics Inc
01/04/202417:00GlobeNewswire Inc.Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CYTKCytokinetics Inc
25/03/202409:15GlobeNewswire Inc.Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific SessionNASDAQ:CYTKCytokinetics Inc
04/03/202418:00GlobeNewswire Inc.Cytokinetics to Participate in March Investor ConferencesNASDAQ:CYTKCytokinetics Inc
01/03/202420:47PR Newswire (US)Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600NASDAQ:CYTKCytokinetics Inc
29/02/202409:30GlobeNewswire Inc.Cytokinetics Joins Global Initiative to Recognize International Rare Disease DayNASDAQ:CYTKCytokinetics Inc
28/02/202409:30GlobeNewswire Inc.Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical TrialsNASDAQ:CYTKCytokinetics Inc
27/02/202418:00GlobeNewswire Inc.Cytokinetics Reports Fourth Quarter 2023 Financial ResultsNASDAQ:CYTKCytokinetics Inc
13/02/202418:00GlobeNewswire Inc.Cytokinetics to Announce Fourth Quarter Results on February 27, 2024NASDAQ:CYTKCytokinetics Inc
06/02/202418:00GlobeNewswire Inc.Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CYTKCytokinetics Inc
29/01/202409:30GlobeNewswire Inc.Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant ProgramNASDAQ:CYTKCytokinetics Inc
25/01/202409:30GlobeNewswire Inc.Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of AficamtenNASDAQ:CYTKCytokinetics Inc
18/01/202415:00GlobeNewswire Inc.Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024NASDAQ:CYTKCytokinetics Inc
12/01/202408:10IH Market NewsWall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and MoreNASDAQ:CYTKCytokinetics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYTK

Seu Histórico Recente

AMEX
YUMA-A
ASX
ARWDA
NASDAQ
GGR
Gogoro
COIN
WCHGBP
CSE
CDVA
CordovaCann
UNSW
CVRETH
PolkaCover
LSE
FLO
Flowtech Fluidpower
BOV
BRFSQ225
BRFSQ225 Ex:22,5
COIN
ETHWETH
Ethereum PoW
TSXV
MED
Medgold Resources
LQID
ASMBTC
NYSE
DMOB
Delimobil
USOTC
WTECQ
Westech Capital (GM)
LSE
FL02
Hsbc Bk.28
NASDAQ
ZIMV
ZimVie
NASDAQ
NPTH
Enpath
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados